Miller Caela, Bidus Michael A, Pulcini Joseph P, Maxwell G Larry, Cosin Jonathan A, Rose G Scott
Department of Obstetrics and Gynecology, National Naval Medical Center, Bethesda, MD, USA.
Am J Obstet Gynecol. 2008 Jul;199(1):69.e1-4. doi: 10.1016/j.ajog.2007.11.070. Epub 2008 Feb 1.
This study was undertaken to determine the clinical relevance of "qualifying comments" on pathology reports of complex atypical endometrial hyperplasia.
A retrospective review of endometrial biopsy specimens with atypical hyperplasia at our institutions was performed if subsequent hysterectomy results were available for review. Endometrial biopsy results were graded on an ordinal scale (complex atypical endometrial hyperplasia vs atypical endometrial hyperplasia "cannot rule out a more severe lesion") and compared with pathology obtained at hysterectomy. Data were analyzed by using Fisher's exact test.
Endometrial biopsy specimens were associated with carcinoma in 37.5% (18/48) of complex atypical endometrial hyperplasia cases and in 60% (18/30) of atypical endometrial hyperplasia-cancer cases. Atypical endometrial hyperplasia-cancer on biopsy was associated with an increased risk of discovering a malignancy at intermediate/high-risk for lymph node involvement (odds ratio 4.71, P = .0256).
Biopsy specimens that show atypical endometrial hyperplasia-cancer are associated with an increased risk of finding a cancer at intermediate or high risk for nodal metastasis.
本研究旨在确定复杂非典型子宫内膜增生病理报告中“限定性评论”的临床相关性。
对本机构有非典型增生的子宫内膜活检标本进行回顾性研究,前提是有后续子宫切除结果可供复查。子宫内膜活检结果按序数量表分级(复杂非典型子宫内膜增生与非典型子宫内膜增生“不能排除更严重病变”),并与子宫切除时获得的病理结果进行比较。采用Fisher精确检验分析数据。
在37.5%(18/48)的复杂非典型子宫内膜增生病例和60%(18/30)的非典型子宫内膜增生-癌病例中,子宫内膜活检标本与癌相关。活检显示非典型子宫内膜增生-癌与在淋巴结受累中/高风险时发现恶性肿瘤的风险增加相关(优势比4.71,P = 0.0256)。
显示非典型子宫内膜增生-癌的活检标本与在淋巴结转移中或高风险时发现癌症的风险增加相关。